The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Ebselen in Acute Ischemic Stroke: A Placebo-Controlled, Double-blind Clinical Trial
Open accessAbstract
Background and Purpose —The effect of ebselen, a seleno-organic compound with antioxidant activity through a glutathione peroxidase–like action, on the outcome of acute ischemic stroke was evaluated in a multicenter, placebo-controlled, double-blind clinical trial. Methods —Patients diagnosed as having acute ischemic stroke who could receive drug treatment within 48 hours of stroke onset were enrolled. Oral administration of ebselen granules suspended in water (150 mg BID) or placebo was started immediately after admission and was continued for 2 weeks. The major end points were the Glasgow Outcome Scale scores at 1 month and 3 months after the start of treatment. The modified Mathew Scale and modified Barthel Index scores at 1 month and 3 months were also studied as secondary outcome measures. Results —Three hundred two patients were enrolled in the trial. Intent-to-treat analysis of 300 patients (151 given ebselen and 149 given placebo) revealed that ebselen treatment achieved a significantly better outcome than placebo at 1 month ( P =.023, Wilcoxon rank sum test) but not at 3 months ( P =.056, Wilcoxon rank sum test). The improvement was significant in patients who started ebselen within 24 hours of stroke onset but not in those who started treatment after 24 hours. There was a corresponding improvement in the modified Mathew Scale and modified Barthel Index scores. Conclusions —Early treatment with ebselen improved the outcome of acute ischemic stroke. Ebselen may be a promising neuroprotective agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ASSESSMENT OF COMA AND IMPAIRED CONSCIOUSNESS
Teasdale, G., & Jennett, B. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91639-0 · Cited by 13,215
ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE A Practical Scale
JENNETT, B. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92830-5 · Cited by 7,501
Fisher, C. M., Kistler, J. P., & Davis, J. M. (1980) · Neurosurgery · doi:10.1227/00006123-198001000-00001 · Cited by 3,080
Pathophysiology and treatment of focal cerebral ischemia: Part I: Pathophysiology
Siesjö, B. K. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.2.0169 · Cited by 1,295
A novel biologically active seleno-organic compound—1
Müller, A., Cadenas, E., Graf, P., & Sies, H. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90083-2 · Cited by 828
Siesjö, B. K. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.77.3.0337 · Cited by 657
Central nervous system trauma and stroke
Hall, E. D., & Braughler, J. M. (1989) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(89)90057-9 · Cited by 586
A novel biologically active seleno-organic compound—II
Wendel, A., Fausel, M., Safayhi, H., Tiegs, G., & Otter, R. (1984) · Biochemical Pharmacology · doi:10.1016/0006-2952(84)90084-4 · Cited by 433
A Controlled Trial of Nimodipine in Acute Ischemic Stroke
Gelmers, H. J., Gorter, K., de Weerdt, C. J., & Wiezer, H. J. A. (1988) · New England Journal of Medicine · doi:10.1056/nejm198801283180402 · Cited by 419
Detection of free radicals during brain ischemia and reperfusion by spin trapping and microdialysis
Zini, I., Tomasi, A., Grimaldi, R., Vannini, V., & Agnati, L. F. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90933-x · Cited by 185
The Reaction of Ebselen with Peroxynitrite
Masumoto, H., & Sies, H. (1996) · Chemical Research in Toxicology · doi:10.1021/tx950115u · Cited by 171
Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51)
Maiorino, M., Roveri, A., Coassin, M., & Ursini, F. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90591-6 · Cited by 167
Takasago, T., Peters, E. E., Graham, D. I., Masayasu, H., & Macrae, I. M. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701426 · Cited by 161
Dawson, D. A., Masayasu, H., Graham, D. I., & Macrae, I. M. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11226-9 · Cited by 145
Predicting discharge status at commencement of stroke rehabilitation.
Shah, S., Vanclay, F. M., & Cooper, B. (1989) · Stroke · doi:10.1161/01.str.20.6.766 · Cited by 143
Armin, M. (1984) · Biochemistry international · Cited by 97
Preferential inhibition of inducible nitric oxide synthase by ebselen
Hattori, R., Inoue, R., Sase, K., Eizawa, H., Kosuga, K., Aoyama, T., Masayasu, H., Kawai, C., Sasayama, S., & Yui, Y. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90179-1 · Cited by 62
ICHIKAWA, S., OMURA, K., Katayama, T., Okamura, N., OHTSUKA, T., Ishibashi, S., & Masayasu, H. (1987) · Journal of Pharmacobio-Dynamics · doi:10.1248/bpb1978.10.595 · Cited by 36
Joseph, D. B., & Bidlack, J. M. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90218-6 · Cited by 32
Effects of Ebselen (PZ 51) on Ischaemic Brain Oedema After Focal Ischaemia in Cats
Johshita, H., Sasaki, T., Matsui, T., Hanamura, T., Masayasu, H., Asano, T., & Takakura, K. (1990) · Springer eBooks · doi:10.1007/978-3-7091-9115-6_80 · Cited by 26
Self-citation
Cited by
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy
Forman, H. J., & Zhang, H. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00233-1 · Cited by 2,900
Adams, H. P., del Zoppo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furlan, A., Grubb, R. L., Higashida, R. T., Jauch, E. C., Kidwell, C., et al. (2007) · Stroke · doi:10.1161/strokeaha.107.181486 · Cited by 2,475
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
Nogueira, C. W., Zeni, G., & Rocha, J. B. T. (2004) · Chemical Reviews · doi:10.1021/cr0406559 · Cited by 1,926
Redox regulation of cell survival
Trachootham, D., Lu, W., Ogasawara, M. A., Valle, N. R.-D., & Huang, P. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1957 · Cited by 1,781
Metadata
- Authors
- Yamaguchi, T., Sano, K., Takakura, K., Saito, I., Shinohara, Y., Asano, T., & Yasuhara, H.
- Venue
- Stroke
- Published
- 1998-01
- Volume
- 29
- Issue
- 1
- Pages
- 12-17
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W1965476204
- Cited by
- 610
- References
- 20
- FWCI
- 16.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.